Prosecution Insights
Last updated: July 17, 2026
Application No. 17/833,783

ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

Non-Final OA §103§112
Filed
Jun 06, 2022
Priority
Jul 14, 2021 — RE 10-2021-0092041 +1 more
Examiner
DEGUIRE, SEAN M
Art Unit
1786
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Rohm and Haas Electronic Materials Korea Ltd.
OA Round
3 (Non-Final)
60%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
168 granted / 281 resolved
-5.2% vs TC avg
Strong +30% interview lift
Without
With
+29.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
54 currently pending
Career history
335
Total Applications
across all art units

Statute-Specific Performance

§103
93.0%
+53.0% vs TC avg
§102
4.0%
-36.0% vs TC avg
§112
2.7%
-37.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 281 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 04/13/2026 has been entered. Claim Rejections - 35 USC § 112(d) The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 11 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 11 allows that X is CR’R’’, a scope outside of claim 1 from which it depends. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-10 are rejected under 35 U.S.C. 103 as being unpatentable over Kwong et al (US 2010/0072887) (Kwong). In reference to claims 1-10, Kwong teaches an organic light emitting device comprising an organic layer between an anode and cathode, wherein the organic layer comprises a dibenzoselenophene of the formula as shown below for use as a hole transport layer (Kwong [0016]; [0036]; [0045]) PNG media_image1.png 146 324 media_image1.png Greyscale for example, wherein R1 is hydrogen, one of Ar is benzene and one of Ar is naphthalene (Kwong [0036]; [0037]). Kwong discloses the dibenzoselenophene compound that encompasses the presently claimed compound, including wherein R1 is hydrogen, one of Ar is benzene and one of Ar is naphthalene. Each of the disclosed substituents from the substituent groups of Kwong are considered functionally equivalent and their selection would lead to obvious variants of the dibenzoselenophene compound. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the instant application, in the absence of unexpected results, to have selected these substituents among those disclosed for the dibenzoselenophene compound to provide the compound described above, which is both disclosed by Kwong and encompassed within the scope of the present claims and thereby arrive at the claimed invention. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Shin et al (US 2016/0351820) (Shin) in view of Kwong et al (US 2010/0072887) (Kwong). In reference to claim 11, Shin teaches a compound of formula (D) as shown below for use in an organic electronic device [0016] [0017]) PNG media_image2.png 268 340 media_image2.png Greyscale for example, wherein in the formula (2), X is O or S, each other R is hydrogen, Ar1 is aryl and Ar3 is a heteroaryl group (Shin [0055] [0035] to [0041]). Shin discloses the compound of formula (2) that encompasses the presently claimed compound, including wherein in the formula (2), X is O or S, each other R is hydrogen, Ar1 is aryl and Ar3 is a heteroaryl group. Each of the disclosed substituents from the substituent groups of Shin are considered functionally equivalent and their selection would lead to obvious variants of the compound of formula (2). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the instant application, in the absence of unexpected results, to have selected these substituents among those disclosed for the compound of formula (2) to provide the compound described above, which is both disclosed by Shin and encompassed within the scope of the present claims and thereby arrive at the claimed invention. Shin does not expressly teach that the heteroaryl group is a dibenzoselephene as instantly claimed. With respect to the difference, Kwong teaches, in analogous art, organoselenium compounds such as dibenzoselenophene compounds substituted with arylamine groups of the formula as shown below and further teaches that hosts containing dibenzoselenophene are excellent host and enhancement layer materials for OLEDs (Kwong p. 6; [0069] [0070]). PNG media_image1.png 146 324 media_image1.png Greyscale In light of the motivation of using dibenzoselenophene hosts as described above, it would therefore have been obvious to one of ordinary skill in the art before the effective filing date of the instant application to use the dibenzoselenophene as described by Kwong in order to provide an excellent host material and thereby arrive at the claimed invention. Response to Arguments Applicant’s arguments with respect to the claims have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Sean M DeGuire whose telephone number is (571)270-1027. The examiner can normally be reached Monday to Friday, 7:00 AM - 5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer A. Boyd can be reached at (571) 272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Sean M DeGuire/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Jun 06, 2022
Application Filed
Aug 07, 2025
Non-Final Rejection mailed — §103, §112
Dec 08, 2025
Response Filed
Jan 16, 2026
Final Rejection mailed — §103, §112
Apr 13, 2026
Request for Continued Examination
Apr 15, 2026
Response after Non-Final Action
Apr 30, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12684936
LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
3y 5m to grant Granted Jul 14, 2026
Patent 12668606
ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE
4y 3m to grant Granted Jun 30, 2026
Patent 12648352
A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
5y 3m to grant Granted Jun 02, 2026
Patent 12642000
ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
5y 3m to grant Granted May 26, 2026
Patent 12630574
ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE
4y 2m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
60%
Grant Probability
90%
With Interview (+29.8%)
4y 0m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 281 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month